Robert Schvarcz
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 39
- Hepatitis C virus research 38
- Liver Diseases and Immunity 8
- Epidemiology 26
- Hepatitis B Virus Studies 18
- Liver Disease Diagnosis and Treatment 17
- Co-authors
- Ola Weiland (27 shared papers)Annette Bruchfeld (7 shared papers)Olle Reichard (7 shared papers)Karin Lindahl (8 shared papers)Jan Andersson (2 shared papers)Lars Ståhle (4 shared papers)Aril Frydén (13 shared papers)Gunnar Norkrans (12 shared papers)
- Journals
- Journal of Hepatology (6 papers)Journal of Viral Hepatitis (6 papers)Hepatology (3 papers)Therapeutic Drug Monitoring (3 papers)Infection (2 papers)
- Partner nations
- SwedenUnited StatesAustria
In The Last Decade
Robert Schvarcz
47 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 91
- Hepatology 1.7k
- Epidemiology 1.2k
- Transplantation 46
- Rheumatology 216
- Infectious Diseases 233
Countries citing papers authored by Robert Schvarcz
This map shows the geographic impact of Robert Schvarcz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schvarcz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schvarcz more than expected).
Fields of papers citing papers by Robert Schvarcz
This network shows the impact of papers produced by Robert Schvarcz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schvarcz. The network helps show where Robert Schvarcz may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Schvarcz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 228 | |
| 2 | 2005 | 169 | |
| 3 | 1997 | 161 | |
| 4 | 2002 | 113 | |
| 5 | 2001 | 109 | |
| 6 | 2005 | 96 | |
| 7 | 1995 | 94 | |
| 8 | 1995 | 90 | |
| 9 | 2004 | 87 | |
| 10 | 1997 | 79 | |
| 11 | Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. | 1995 | 64 |
| 12 | 1989 | 63 | |
| 13 | 1993 | 59 | |
| 14 | 1990 | 56 | |
| 15 | 1990 | 54 | |
| 16 | 1997 | 49 | |
| 17 | 2000 | 48 | |
| 18 | 2000 | 46 | |
| 19 | 1995 | 41 | |
| 20 | 1991 | 41 |
About Robert Schvarcz
Robert Schvarcz is a scholar working on Hepatology, Epidemiology, Rheumatology, Infectious Diseases and Molecular Biology, having authored 48 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (38 papers), Hepatitis B Virus Studies (18 papers), Liver Disease Diagnosis and Treatment (17 papers), Liver Diseases and Immunity (8 papers), Systemic Lupus Erythematosus Research (6 papers), HIV/AIDS drug development and treatment (5 papers), Spondyloarthritis Studies and Treatments (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Hepatology (1.7k citations), Epidemiology (1.2k citations), Transplantation (46 citations), Rheumatology (216 citations) and Infectious Diseases (233 citations). Robert Schvarcz has collaborated with scholars based in Sweden, United States and Austria. Frequent co-authors include Ola Weiland, Annette Bruchfeld, Olle Reichard, Karin Lindahl, Jan Andersson, Lars Ståhle, Aril Frydén, Gunnar Norkrans, Hans Glaumann and Elisabeth Ståhle. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, Hepatology, Therapeutic Drug Monitoring and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.